Early-Stage Potency Assay Development for Regenerative Cell Therapies
Time: 12:00 pm
day: Conference Day One - Track B - AM
Details:
• Leveraging advanced technologies to increase understanding of drug product mechanism of action towards establishing a meaningful matrix of functional assays
• Developing phase appropriate early-stage potency assays for the characterization of pluripotent stem cell-derived regenerative medicines
• Moving from a characterization matrix to a suitable assay for drug product release and stability testing
